Aristotle University Of Thessaloniki (AUTH)
Η χρησιμοποίηση της μιτοκίνης-C ως συμπλήρωματικής θεραπείας σε εγχειρήσεις πτερυγίου
Abstract
dc:descriptionIntroduction'. Pterygium, a common ocular surface disorder in Greeks, tends to recur after its surgical excision. Various adjunctive methods may be used in order to reduce pterygium recurrence and mitomycin C is one of them.Aims: As there is little experience in the use of mitomycin C in Greek pterygium patients, the aim of the study is to evaluate the intraoperative use of MMC in pterygium surgery and to yield conclusions for the efficacy and the safety of this adjunctive method. Moreover, to define the indications, the way of the procedure, and rules for the selection of the patients.Material: The sample of the study included 78 patients with pterygium (primary and reçurent) fulfilling the inclusion criteria after their examination at the University Eye Clinic of Thessaloniki. 55% of the patients were men (mean age 59,6 years) and 45% women (mean age 60,4 years). The proffession of the patients was outdoors in 73%, indoors 20,5% and indoors but in adverse conditions 6,5%.Methods: A full history from all the 78 patients was taken and afterwards they had a complete ophthalmic examination along with a photographic documentation of the pterygium. After pterygium excision under the bare- sclera technique in all patients, 39 patients were randomly selected for the intraoperative use of MMC. MMC of 0,02% was used intraoperatively for 5 minutes on the bare sclera. All patients were followed-up on 1st and 7th day postoperatively, and then at the end of 1st, 3rd, 6th, 9th, 12th, 18th and 24th month. Patients were asked for symptoms and were examined for pathologic signs. Visual aquity, keratometry and I.O.P. were also documented. The recurrence was evaluated in primary and reçurent pterygiums, along with relations to age, sex and profession. The least follow-up was 2 years for both groups, while it was longer for the mitomycin group.Results: The recurrence in the MMC group was 15,4% (20% in primary and 10,5% in reçurent pterygium), while it was 53,8% (54,5% in primary and 50% in reçurent pterygium) in the control group. The diffemce is statistically very241important (p<0,001). The possibility of recurence was 6,5 times higher in the control group than in the MMC group. The decrease of pterygium recurrence by the MMC was important in all age, sex and proffessional groups. However, MMC is more effective in young adults up to 50 years old (p=0,049) and in women (p=0,025). Pterygium recurrence had no significant correlations with age (p=0,308 andp=l,0) or proffession (p=0,305 andp=0,682) for the MMC and the control group respectively. The sex of the patient was correlated with the recurrence only in the MMC group (p=0,046). All the recurrences developed in the first postoperative year, and most of them in the first 9 months. Recurrences were small in the majority of the cases and far away from the optical zone.Side effects and complications that were seen more often in the MMC group were: conjunctival hyperemia (56,4%), delayed conjunctivalepithelialization (66%), Dellen (15,4%), conjunctival granuloma (12,8%), mild temporary increase in I.O.P. (12,8%) and mild Symblepharon (10,3%). The difference between the two grooups was not statistically important for all the complicatios but for the hyperemia (p<0,001).Conclusions·. Mitomycin C 0,02% intraoperatively for 5 minutes, causes a significant reduction in pterygium recurrence, while the complications are mild and temporary. The intaroperative use of MMC in pterygium surgery is effective and safe when rules for the selection of the patients and the way of the procedure are kept.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2003
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papandroudis, Andreas
- Παπανδρούδης, Ανδρέας
Subjects
dc:subject × 11Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/13958